Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Clinical trial NCT02106182 · COMPLETED
Trial details
- NCT number
- NCT02106182
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-02
- Primary completion
- 2016-03-02
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.